Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity (Q44971172)
Jump to navigation
Jump to search
scientific article published in July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity |
scientific article published in July 2004 |
Statements
1 reference
Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity (English)
1 reference
Paul Richardson
1 reference
Kenneth Anderson
1 reference
Robert Knight
1 reference
Teru Hideshima
1 reference
Constantine Mitsiades
1 reference
Robert Schlossman
1 reference
Andrea Freeman
1 reference
Jerome Zeldis
1 reference
Sundar Jagannath
1 reference
Melissa Alsina
1 reference
Faith Davies
1 reference
Raman Desikan
1 reference
Emily Blood
1 reference
Edie Weller
1 reference
Deborah Doss
1 reference
Joan Bosch
1 reference
John Patin
1 reference
William Dalton
1 reference
1 July 2004
1 reference
1 reference
79
1 reference
7
1 reference
875-882
1 reference
Identifiers
1 reference
1 reference